Bernie Sanders on lobbying: what the evidence says · JRE #1330
SUBJECT: LOBBYING
Not a true/false call. Every claim is logged with its sources; read the exhibits below.
Over the last 20 years, the drug companies alone have spent $4.5 billion in 20 years on lobbying and campaign contributions.
What the evidence says 01 / RECORD
Sanders claimed pharmaceutical companies spent $4.5 billion over the prior 20 years on lobbying and campaign contributions combined. A peer-reviewed JAMA Internal Medicine study of federal and state disclosure data found the pharmaceutical and health-product industry spent $4.7 billion on federal lobbying alone between 1999 and 2018, plus roughly $1.29 billion in campaign contributions to federal and state candidates and committees over the same period, a combined total near $6 billion. Sanders' $4.5 billion figure closely tracks the lobbying-only total for a comparable 20-year window but understates the combined lobbying-and-contributions total the study documents. Separately, a 2021 PolitiFact review of a related but distinct Sanders claim (about the number of pharma lobbyists on Capitol Hill) rated it "Half True" for mixing pharmaceutical lobbyists with lobbyists from other health-product sectors, and reporting on OpenSecrets' methodology shows industry-wide lobbying and contribution totals can be sensitive to how figures are aggregated. Neither of those two sources directly evaluates this specific dollar figure; they are offered as context on how aggregate industry spending claims can be constructed differently. Overall, the order of magnitude in Sanders' claim is well-supported by the best available tracking data for the period, though it describes as a single "lobbying and campaign contributions" total a figure that most closely corresponds to lobbying expenditures alone.